🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

Business • November 18, 2026 •
Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy
The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Retirement Health Care"
"Free Quote Today"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"We build AI or anything ICST"
"Get your business promoted today."